Intellia Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Recent Company Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. SPY
2. AVAV
3. NVDA
4. EOSE
5. NKE
6. MU
7. DLR
8. AAPL
9. TSLA
10. VSH

Go back to Intellia Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics (NTLA) Misses Q3 EPS by 13c; Cash and Cash Equivalents of $1.15B

November 4, 2021 7:52 AM EDT

Intellia Therapeutics (NASDAQ: NTLA) reported Q3 EPS of ($0.97), $0.13 worse than the analyst estimate of ($0.84). Revenue for the quarter came in at $7.2 million versus the consensus estimate of $8.66 million.

For earnings history and earnings-related data on Intellia Therapeutics (NTLA) click here.

... More